Related Experiment Video

Updated: Mar 31, 2026

Author Spotlight: Innovative Techniques for ROS Detection and Implications for Platelet Research
06:35

Author Spotlight: Innovative Techniques for ROS Detection and Implications for Platelet Research

Published on: March 29, 2024

1.3K

Nutritional and therapeutic approaches to modulate NADPH oxidase-derived ROS signaling in platelets

Francesco Violi1, Daniele Pastori, Roberto Carnevale

  • 1I ClinicaMedica, Sapienza University Rome, Viale del Policlinico 155, Roma 00161, Italy. francesco.violi@uniroma1.it.

Current Pharmaceutical Design
|October 30, 2015
PubMed

Insights

Reactive oxidant species (ROS) contribute to thrombosis. Nutrients like olive oil and cocoa, plus drugs like statins, may inhibit platelet ROS formation, offering potential antiplatelet therapies.

Area of Science:

  • Cardiovascular Research
  • Biochemistry
  • Nutritional Science

Background:

  • Intra-platelet reactive oxidant species (ROS) formation is linked to thrombosis.
  • Enhanced ROS production in platelets is associated with severe thrombotic events and mortality.
  • Nutritional and pharmacological strategies are being explored to manage ROS-mediated thrombus formation.

Purpose of the Study:

  • To review evidence on polyphenol-rich nutrients (olive oil, cocoa) and statins as antiplatelet agents.
  • To examine their interference with Nicotinamide Adenine Dinucleotide Phosphate (NADPH) Oxidase signaling.
  • To highlight the role of platelet NADPH oxidase-derived ROS in antiplatelet activity.

Main Methods:

  • Literature review of experimental and clinical studies.
  • Analysis of data on antioxidant-rich foods and drug effects on oxidative stress.
  • Investigation of mechanisms involving platelet NADPH oxidase and ROS signaling pathways.

Main Results:

  • Polyphenol-rich foods and statins demonstrate potential to modulate ROS formation.
  • Antiplatelet effects appear linked to inhibition of platelet NADPH oxidase-derived ROS.
  • This inhibition leads to reduced pro-aggregating isoprostanes and increased platelet-inhibiting nitric oxide.

Conclusions:

  • Nutrients and statins show promise as antiplatelet agents by targeting platelet ROS.
  • Modulating platelet NADPH oxidase-derived ROS is a key mechanism for their antiplatelet activity.
  • Further research into these agents could lead to novel therapeutic strategies for thrombosis.

More Related Videos

Platelet-based Detection of Nitric Oxide in Blood by Measuring VASP Phosphorylation07:13

Platelet-based Detection of Nitric Oxide in Blood by Measuring VASP Phosphorylation

Published on: January 7, 2019

8.5K
Ferric Chloride-induced Murine Thrombosis Models10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

23.5K

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.5K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.6K
Peroxisomes01:24

Peroxisomes

Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
22.1K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.7K
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.8K